BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 168232)

  • 1. Studies of the elevated extracellular concentration of cyclic AMP in uremic man.
    Hamet P; Stouder DA; Ginn HE; Hardman JG; Liddle GW
    J Clin Invest; 1975 Aug; 56(2):339-45. PubMed ID: 168232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Calcitonin sensitivity testing in patients with kidney diseases. Changes in serum calcium, phosphorus and plasma cyclic adenosine monophosphate levels under the effect of calcitonin in healthy subjects and uremic patients under chronic hemodialysis].
    Szücs J; Steczek K
    Orv Hetil; 1978 May; 119(20):1220-4. PubMed ID: 206866
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of salmon calcitonin on renal excretion of adenosine 3', 5' monophosphate in man.
    Ardaillou R; Isaac R; Nivez MP; Kuhn JM; Cazor JL; Fillastre JP
    Horm Metab Res; 1976 Mar; 8(2):136-40. PubMed ID: 177347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red blood cell calcium homeostasis in patients with end-stage renal disease.
    Gafter U; Malachi T; Barak H; Djaldetti M; Levi J
    J Lab Clin Med; 1989 Sep; 114(3):222-31. PubMed ID: 2527934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of serum reverse triiodothyronine and thyroxine kinetics in chronic renal failure: role of nutritional status, chronic illness, uremia, and hemodialysis.
    Kaptein EM; Feinstein EI; Nicoloff JT; Massry SG
    Kidney Int Suppl; 1983 Dec; 16():S180-6. PubMed ID: 6588250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chlorpropamide on renal response to parathyroid hormone in normal subjects and in patients with hypoparathyroidism and pseudohypoparathyroidism.
    Coulson R; Moses AM
    J Pharmacol Exp Ther; 1975 Sep; 194(3):603-13. PubMed ID: 169346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxalic Acid as a uremic toxin.
    Mydlík M; Derzsiová K
    J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F; Floridi AG; Floridi A; Buoncristiani U
    Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Raised cAMP content of striated muscle in experimental chronic renal failure (author's transl)].
    Schmidt G; Fricke L; Hempel K; Heidland A
    Dtsch Med Wochenschr; 1975 Nov; 100(46):2397-8. PubMed ID: 171131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination and serum protein binding of phenylbutazone in patients with renal insufficiency.
    Held H; Enderle C
    Clin Nephrol; 1976 Sep; 6(3):388-93. PubMed ID: 136326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated plasma and urinary guanosine 3':5'-monophosphate and increased production rate in patients with neoplastic diseases.
    Chawla RK; Shlaer SM; Lawson DH; Murray TG; Schmidt F; Shoji M; Nixon DW; Richmond A; Rudman D
    Cancer Res; 1980 Nov; 40(11):3915-20. PubMed ID: 6258769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of urinary concentration in nephrogenic diabetes insipidus.
    McConnell RF; Lorentz WB; Berger M; Smith EH; Carvajal HF; Travis LB
    Pediatr Res; 1977 Jan; 11(1 Pt 1):33-6. PubMed ID: 188007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrogenous adenosine 3'5' monophosphate as an index of parathyroid function in chronic renal disease.
    Czekalski S; Baczyk K
    Proc Eur Dial Transplant Assoc; 1977; 14():451-60. PubMed ID: 202946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma clearance of pyridoxal 5'-phosphate in vitamin B6-deficient uremic man.
    Spannuth CL; Warnock LG; Wagner C; Stone WJ
    J Lab Clin Med; 1977 Oct; 90(4):632-7. PubMed ID: 903695
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma amino acid profile and L-arginine uptake in red blood cells from malnourished uremic patients.
    Reis PF; da Silva CD; Brunini TM; Moss MB; Siqueira MA; Santos SF; Roberts NB; Ellory JC; Mann GE; Mendes-Ribeiro AC
    J Ren Nutr; 2006 Oct; 16(4):325-31. PubMed ID: 17046616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the endocrinological metabolism of the parathyroid. I. The production of renal calcinosis by cyclic AMP injection in rat].
    Kohri K; Takada M; Katoh Y; Kataoka K; Iguchi M; Kurita T; Yachiku S
    Hinyokika Kiyo; 1985 Dec; 31(12):2141-8. PubMed ID: 3008537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total parathyroidectomy: parathyroid hormone levels and supernumerary glands in hemodialysis patients.
    Meakins JL; Milne CA; Hollomby DJ; Goltzman D
    Clin Invest Med; 1984; 7(1):21-5. PubMed ID: 6723120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated plasma adenine nucleotide levels in chronic renal failure and their possible significance.
    Moss AH; Solomons CC; Alfrey AC
    Proc Clin Dial Transplant Forum; 1979; 9():184-8. PubMed ID: 399505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.